Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Australia Insists Orphan Designations Will Last Only Six Months, Overrides Industry Objections
Apr 19 2017
•
By
Neena Brizmohun
Australian orphan drug designations are to lapse after just six months
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Rare Diseases
More from Pink Sheet